StonvexLoading…
StonvexStonvexStonvexCore line items from MNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.35B | $8.29B | $6.16B | $3.97B |
Operating Income | $729.96M | $2.42B | $1.88B | $1.20B |
Net Income | $569.49M | $1.91B | $1.46B | $488.79M |
EPS (Diluted) | $0.58 | $1.94 | $1.48 | $0.95 |
Total Assets | $10.84B | $9.99B | $9.61B | $8.73B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.04B | $2.09B | $2.29B | $1.93B |
Free Cash Flow OCF − CapEx | $584.38M | $1.97B | $1.61B | $913.16M |
Shares Outstanding | 977.92M | 978.11M | 977.00M | 976.40M |